MENU

XRTX XORTX Therapeutics Inc. Forecast, Technical & Fundamental Analysis

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKE42.740.70
+1.67%
Buckle (The)
BWAY8.98-0.13
-1.43%
Brainsway Ltd.
BMNR15.47-0.39
-2.46%
BitMine Immersion Technologies Inc.
BSIN1.01-0.05
-4.72%
Big Sky Industrial Inc
OGEN0.19-0.02
-10.00%
Oragenics

XRTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with BCDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
N/A
BCDA - XRTX
43%
Loosely correlated
-2.06%
BYSI - XRTX
26%
Poorly correlated
-19.09%
CLNN - XRTX
26%
Poorly correlated
+6.21%
MIST - XRTX
26%
Poorly correlated
+11.42%
DOMH - XRTX
24%
Poorly correlated
+21.53%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
3710 - 33rd Street NW
Phone
+1 403 455-7727
Employees
17
Web
https://www.xortx.com
XORTX Therapeutics (XRTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com